Researchers compare long-term outcomes of two biologics in managing Crohn’s disease of the pouch, focusing on clinical response, remission rates, and adverse event profiles in a real-world multicenter setting.
As public awareness rises, doctors are being called to bridge the knowledge gap, offer screening, and guide patients through complex and evolving risks.
Patients from the MeninGene study contributed serum samples over 5 years, revealing that autoimmune processes rarely drive long-term cognitive problems after bacterial meningitis.
Researchers identified segment-specific effects of immune cells on intestinal contractions, providing new angles for managing inflammatory bowel disease.